At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 600 target
Drug / intervention
cf-circRNA assayother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
In Brief
An observational study evaluating cf-circRNA assay for Colorectal Cancer. Currently recruiting, targeting 600 participants across 1 site.
Detailed Summary
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesUnited States
Collaborators--
Timeline
N/ARecruitingOverdue
20252026
Enrollment StartJan 2025
First PostedNov 2025
Primary CompletionJun 2026
TodayJul 2026
First PostedNov 5, 2025
Enrollment StartJan 15, 2025
Primary CompletionJun 18, 2026
TodayJul 1, 2026
Enrollment to primary: 1.4 yearsPosted 8 months ago
Interventions
cf-circRNA assayother
Circular RNA detection in plasma or serum by RT-qPCR